Citius Pharmaceuticals
CTXR
CTXR
58 hedge funds and large institutions have $11.8M invested in Citius Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 25 reducing their positions, and 21 closing their positions.
Holders
58
Holders Change
-14
Holders Change %
-19.44%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
25
Closed
21
Calls
$106K
Puts
$20K
Net Calls
+$86K
Net Calls Change
+$72K
Top Buyers
| 1 |
1
Squarepoint
New York
|
$330K |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$941K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$3.23M |
| 4 |
VF
4
Virtu Financial
New York
|
$50K |
| 5 |
XT
5
XTX Topco
George Town,
Cayman Islands
|
$46.7K |
Top Sellers
| 1 |
AC
1
Armistice Capital
New York
|
$3.64M |
| 2 |
2
Goldman Sachs
New York
|
$19K |
| 3 |
3
Millennium Management
New York
|
$580K |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$160K |
| 5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$82.6K |
